Skip to main content
. 2020 Aug 25;20(5):7. doi: 10.3892/etm.2020.9135

Table I.

Clinicopathological characteristics and UBR5 expression in patients with gastric cancer.

  UBR5 expression (n)  
Variable Total (n) Low High P-value
Gender       0.7009
     Male 75 25 50  
     Female 37 11 26  
Age (years)       0.5826
     ≥56 54 16 38  
     <56 58 20 38  
Tumor size (cm)       <0.05
     ≥3 97 25 72  
     <3 15 11 4  
TNM stage       <0.05
     I 19 10 9  
     II, III 93 26 77  
Lymph node metastasis       <0.05
     Positive 79 19 60  
     Negative 33 17 16  
UBR5 expression        
     ≥0.9945 76      
     <0.9945 36